Login / Signup

The decision-making process and criteria in selecting candidate drugs for progeria clinical trials.

Leslie B GordonMark W KieranMonica E KleinmanTom Misteli
Published in: EMBO molecular medicine (2016)
Keyphrases
  • decision making
  • clinical trial
  • phase ii
  • double blind
  • randomized controlled trial